551 related articles for article (PubMed ID: 23929305)
1. Glanzmann thrombasthenia: state of the art and future directions.
Nurden AT; Pillois X; Wilcox DA
Semin Thromb Hemost; 2013 Sep; 39(6):642-55. PubMed ID: 23929305
[TBL] [Abstract][Full Text] [Related]
2. Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment.
Nurden AT; Pillois X; Nurden P
Expert Rev Hematol; 2012 Oct; 5(5):487-503. PubMed ID: 23146053
[TBL] [Abstract][Full Text] [Related]
3. Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort.
Nurden AT; Pillois X; Fiore M; Alessi MC; Bonduel M; Dreyfus M; Goudemand J; Gruel Y; Benabdallah-Guerida S; Latger-Cannard V; Négrier C; Nugent D; Oiron RD; Rand ML; Sié P; Trossaert M; Alberio L; Martins N; Sirvain-Trukniewicz P; Couloux A; Canault M; Fronthroth JP; Fretigny M; Nurden P; Heilig R; Vinciguerra C
Hum Mutat; 2015 May; 36(5):548-61. PubMed ID: 25728920
[TBL] [Abstract][Full Text] [Related]
4. Glanzmann thrombasthenia-like syndromes associated with Macrothrombocytopenias and mutations in the genes encoding the αIIbβ3 integrin.
Nurden AT; Pillois X; Fiore M; Heilig R; Nurden P
Semin Thromb Hemost; 2011 Sep; 37(6):698-706. PubMed ID: 22102273
[TBL] [Abstract][Full Text] [Related]
5. In silico analysis of structural modifications in and around the integrin αIIb genu caused by ITGA2B variants in human platelets with emphasis on Glanzmann thrombasthenia.
Pillois X; Peters P; Segers K; Nurden AT
Mol Genet Genomic Med; 2018 Mar; 6(2):249-260. PubMed ID: 29385657
[TBL] [Abstract][Full Text] [Related]
6. Novel mutations of integrin αIIb and β3 genes in Turkish children with Glanzmann's thrombasthenia.
Tokgoz H; Torun Ozkan D; Caliskan U; Akar N
Platelets; 2015; 26(8):779-82. PubMed ID: 25734216
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia.
Fang J; Hodivala-Dilke K; Johnson BD; Du LM; Hynes RO; White GC; Wilcox DA
Blood; 2005 Oct; 106(8):2671-9. PubMed ID: 15972454
[TBL] [Abstract][Full Text] [Related]
8. Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models.
Nurden AT; Fiore M; Nurden P; Pillois X
Blood; 2011 Dec; 118(23):5996-6005. PubMed ID: 21917754
[TBL] [Abstract][Full Text] [Related]
9. Should studies on Glanzmann thrombasthenia not be telling us more about cardiovascular disease and other major illnesses?
Nurden AT
Blood Rev; 2017 Sep; 31(5):287-299. PubMed ID: 28395882
[TBL] [Abstract][Full Text] [Related]
10. Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patients.
Nelson EJ; Nair SC; Peretz H; Coller BS; Seligsohn U; Chandy M; Srivastava A
J Thromb Haemost; 2006 Aug; 4(8):1730-7. PubMed ID: 16879215
[TBL] [Abstract][Full Text] [Related]
11. A novel Pro126His beta propeller mutation in integrin alphaIIb causes Glanzmann thrombasthenia by impairing progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.
Shen WZ; Ding QL; Jin PP; Wang XF; Jiang YZ; Li SM; Wang HL
Blood Cells Mol Dis; 2009; 42(1):44-50. PubMed ID: 18976939
[TBL] [Abstract][Full Text] [Related]
12. A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.
Ruiz C; Liu CY; Sun QH; Sigaud-Fiks M; Fressinaud E; Muller JY; Nurden P; Nurden AT; Newman PJ; Valentin N
Blood; 2001 Oct; 98(8):2432-41. PubMed ID: 11588040
[TBL] [Abstract][Full Text] [Related]
13. Glanzmann thrombasthenia: genetic basis and clinical correlates.
Botero JP; Lee K; Branchford BR; Bray PF; Freson K; Lambert MP; Luo M; Mohan S; Ross JE; Bergmeier W; Di Paola J;
Haematologica; 2020 Apr; 105(4):888-894. PubMed ID: 32139434
[TBL] [Abstract][Full Text] [Related]
14. C560Rβ3 caused platelet integrin αII b β3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality.
Fang J; Nurden P; North P; Nurden AT; Du LM; Valentin N; Wilcox DA
J Thromb Haemost; 2013 Jun; 11(6):1163-71. PubMed ID: 23551977
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein IIb Leu214Pro mutation produces glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa.
Grimaldi CM; Chen F; Wu C; Weiss HJ; Coller BS; French DL
Blood; 1998 Mar; 91(5):1562-71. PubMed ID: 9473221
[TBL] [Abstract][Full Text] [Related]
16. Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogs.
Fang J; Jensen ES; Boudreaux MK; Du LM; Hawkins TB; Koukouritaki SB; Cornetta K; Wilcox DA
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9583-8. PubMed ID: 21606353
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutations.
Sandrock-Lang K; Oldenburg J; Wiegering V; Halimeh S; Santoso S; Kurnik K; Fischer L; Tsakiris DA; Sigl-Kraetzig M; Brand B; Bührlen M; Kraetzer K; Deeg N; Hund M; Busse E; Kahle A; Zieger B
Thromb Haemost; 2015 Apr; 113(4):782-91. PubMed ID: 25373348
[TBL] [Abstract][Full Text] [Related]
18. Two homozygous missense mutations in ITGB3 gene as a cause of Glanzmann Thrombasthenia in four consanguineous Pakistani pedigrees.
Ali T; Gul S; Amar A; Shakoor M; Farhan S; Mohsin S; Khaliq S
Int J Lab Hematol; 2020 Oct; 42(5):628-635. PubMed ID: 32558238
[TBL] [Abstract][Full Text] [Related]
19. Identification of one novel pathogenic
Lu Z; Nikuze L; Zhong Z; Li F; Zhang F; Liang K; Wei M; Wei H
Platelets; 2020; 31(3):355-359. PubMed ID: 31088191
[TBL] [Abstract][Full Text] [Related]
20. SINE-VNTR-Alu retrotransposon insertion as a novel mutational event underlying Glanzmann thrombasthenia.
Zhang J; Tang J; Li G; Li N; Wang J; Yao R; Yu T
J Thromb Haemost; 2023 Dec; 21(12):3597-3607. PubMed ID: 37604334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
